Generic Name
Trihexyphenidyl
FDA approval date: November 01, 1987
Form: Syrup, Tablet, Solution
What is Trihexyphenidyl?
Trihexyphenidyl HCl is indicated as an adjunct in the treatment of all forms of parkinsonism . It is often useful as adjuvant therapy when treating these forms of parkinsonism with levodopa. Additionally, it is indicated for the control of extrapyramidal disorders caused by central nervous system drugs such as the dibenzoxazepines, phenothiazines, thioxanthenes, and butyrophenones.
Approved To Treat
Top Global Experts
There are no experts for this drug
Save this treatment for later
Not sure about your diagnosis?
Related Clinical Trials
There is no clinical trials being done for this treatment
Related Latest Advances
There is no latest advances for this treatment